ARCHIVES

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

November 19, 2004

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Teddy DeVita’s Courageous Fight Ends At Age 17

June 6, 1980

Clearinghouse Members Names, First Meeting Scheduled For Nov. 8-9

September 24, 1976

Cancer Letter Accepts “Substantial” Settlement In New Copyright Claim

August 5, 1988

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989